IA
ADAP

IFG Advisory’s Adaptimmune Therapeutics ADAP Stock Holding History

IFG Advisory’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$2.81K Buy
11,725
+1,725
+17% +$413 ﹤0.01% 736
2025
Q1 		$1.97K Buy
+10,000
New +$1.97K ﹤0.01% 674
2024
Q4 		– Sell
-27,500
Closed -$26.1K – 673
2024
Q3 		$26.1K Buy
+27,500
New +$26.1K ﹤0.01% 384